BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32311893)

  • 1. [The prognostic significance of POD24 in 106 cases with splenic marginal lymphoma with bone marrow invasion].
    Lyu R; Yan YT; Yi SH; Wang TY; Deng SH; Liu W; Huang WY; An G; Sui WW; Zou DH; Qiu LG; Li ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):228-233. PubMed ID: 32311893
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation.
    Bastidas-Mora G; Beà S; Navarro A; Gine E; Costa D; Delgado J; Baumann T; Magnano L; Rivas-Delgado A; Villamor N; Colomer D; Lopez-Guerra M; Rozman M; Balagué O; Martínez D; Baptista MJ; Escoda L; Alcoceba M; Blanes M; Climent F; Campo E; Wotherspoon A; López-Guillermo A; Matutes E
    Br J Haematol; 2022 Jan; 196(1):146-155. PubMed ID: 34519021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumors of lymphoid and hematopoietic tissue of spleen: a clinicopathologic analysis of 53 cases].
    Chen DB; Shen DH; Zhang H; Wang Y; Song QJ; Yang SM; Fang XZ
    Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):775-781. PubMed ID: 29136691
    [No Abstract]   [Full Text] [Related]  

  • 4. [Analysis of Clinical Curative Efficacy for 91 Cases of Splenic Marginal Lymphoma].
    Lyu R; Yi SH; Li ZJ; Liu W; Li H; Xiong WJ; Qiu LG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1309-13. PubMed ID: 26524028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
    Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
    Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
    Ponzoni M; Kanellis G; Pouliou E; Baliakas P; Scarfò L; Ferreri AJ; Doglioni C; Bikos V; Dagklis A; Anagnostopoulos A; Ghia P; Stamatopoulos K; Papadaki T
    Am J Surg Pathol; 2012 Nov; 36(11):1609-18. PubMed ID: 23073320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idelalisib and Rituximab in 17p Deletion-Positive Splenic Marginal Zone Lymphoma.
    Philip AZ
    J Natl Compr Canc Netw; 2018 Mar; 16(3):230-233. PubMed ID: 29523661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of prognosis following early disease progression in peripheral T-cell lymphoma.
    Suzuki Y; Yano T; Suehiro Y; Iwasaki H; Hidaka M; Otsuka M; Sunami K; Ikeda H; Sawamura M; Ito T; Iida H; Nagai H
    Int J Hematol; 2020 Dec; 112(6):817-824. PubMed ID: 32886278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of POD24 in peripheral T-cell lymphoma.
    Chen H; Ma R; Zhang Q; Lu F; Ma Y; Zhou J; Cao J; Qi K; Yan Z; Sang W; Zhu F; Sun H; Li D; Li Z; Cheng H; Xu K; Chen W
    Hematology; 2024 Dec; 29(1):2304483. PubMed ID: 38251872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas-Retrospective and Multicentric Analysis of Portuguese Centers.
    Rodrigues CD; Peixeiro RP; Viegas D; Chorão P; Couto ME; Gaspar CL; Fernandes JP; Alves D; Ribeiro LA; de Vasconcelos M P; Tomé AL; Badior M; Coelho H; Príncipe F; Chacim S; da Silva MG; Coutinho R
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e839-e844. PubMed ID: 34326035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features of splenic tumours of lymphoid tissue.
    Chen DB; Shen DH; Yang SM; Fang XZ
    Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma.
    Lyu R; Wang T; Wang Y; Xiong W; Wang H; Yan Y; Wang Q; Liu W; An G; Huang W; Sui W; Xu Y; Zou D; Wang J; Qiu L; Yi S
    Br J Haematol; 2021 Sep; 194(5):862-869. PubMed ID: 34328213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.
    Camacho FI; Mollejo M; Mateo MS; Algara P; Navas C; Hernández JM; Santoja C; Solé F; Sánchez-Beato M; Piris MA
    Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of blood and bone marrow examination in the diagnosis of mature lymphoid neoplasms in patients presenting with isolated splenomegaly.
    Sreedharanunni S; Sachdeva MU; Malhotra P; Ahluwalia J; Naseem S; Prakash G; Khadwal A; Sharma P; Kumar N; Varma N; Varma S; Das R
    Hematology; 2015 Oct; 20(9):530-7. PubMed ID: 25760312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study.
    Pich A; Fraire F; Fornari A; Bonino LD; Godio L; Bortolin P; Chiusa L; Palestro G
    Eur J Haematol; 2006 May; 76(5):392-8. PubMed ID: 16480431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics of splenic marginal zone lymphoma with abnormal complete blood count].
    Yang SM; Jiang Q; Jiang B; Chen DB; Wang J; Jiang H; Lu J; Lu XJ; Bao L; Shi HX; Liu YR; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):87-94. PubMed ID: 23484698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study.
    Luminari S; Merli M; Rattotti S; Tarantino V; Marcheselli L; Cavallo F; Varettoni M; Bianchi B; Merli F; Tedeschi A; Cabras G; Re F; Visco C; Torresan Delamain M; Cencini E; Spina M; Ferrero S; Ferrari A; Deodato M; Mannina D; Annibali O; Rago A; Orsucci L; Defrancesco I; Frigeni M; Cesaretti M; Arcaini L
    Blood; 2019 Sep; 134(10):798-801. PubMed ID: 31292118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients.
    Boveri E; Arcaini L; Merli M; Passamonti F; Rizzi S; Vanelli L; Rumi E; Rattotti S; Lucioni M; Picone C; Castello A; Pascutto C; Magrini U; Lazzarino M; Paulli M
    Ann Oncol; 2009 Jan; 20(1):129-36. PubMed ID: 18718888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
    Xing KH; Kahlon A; Skinnider BF; Connors JM; Gascoyne RD; Sehn LH; Savage KJ; Slack GW; Shenkier TN; Klasa R; Gerrie AS; Villa D
    Br J Haematol; 2015 May; 169(4):520-7. PubMed ID: 25854936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.